Outcomes after Transplant in Relapsed/Refractory KMT2Ar (MLLr) and mNPM1 (NPM1c) leukemia Patients Achieving Remissions after Menin Inhibition: SNDX-5613 (revumenib) Ph1 Experience

Authors :: Ghayas C. Issa
Branko Cuglievan
Eytan Stein
Martha L. Arellano
Andrius Žucenka
Nandita Khera
Richard M. Stone
Michael J. Thirman
John F. DiPersio
Nicole Karras
Yu Gu
Rebecca G. Bagley
Galit Rosen
David Tamang
Kimberly Dishman
Sushama Scalera
Michael L. Meyers
Kate Madigan
Nicole McNeer
Ibrahim Aldoss
Source :: Blood. 140:914-916
Publication Year :: 2022
Publisher :: American Society of Hematology, 2022.

Tools